TimeMagazine Alejandra and Marisol Gerardo are nine years old but already making a little bit of history. The twin sisters are among the first young children to get vaccinated with a COVID-19 shot in Pfizer-BioNTech’s study of its vaccine in kids under age 12. Alejandra and Marisol had their blood drawn in the morning on March … Read more
If you’re like most Americans, the past year has been a time of fear, anxiety and often profound tedium—but also of worsening dietary habits. Take 328 million people and confine them to their homes for weeks and months on end and they’re going to start eating more and exercising less. That means, no surprise, weight … Read more
Last March, friends and neighbors began stopping Emily Smith in her town outside of Waco, Texas, with questions about the coronavirus. An epidemiologist at Baylor University, Smith knows all too well how viruses are transmitted. But as the wife of a pastor and as a woman of faith, she also holds a trusted position in … Read more
In an unusual move, on March 23 the U.S. National Institute of Allergy and Infectious Diseases (NIAID) issued a strongly worded statement asking AstraZeneca to “ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.” On March 22, AstraZeneca released the results of its long-awaited U.S. trial of its COVID-19 vaccine, … Read more
Andrea Norred wasn’t too surprised to learn that many of her friends, as well as her 18-year-old son, have decided not to get vaccinated against COVID-19. She lives in Santa Cruz, Calif., a coastal city with an above-average rate of vaccine skepticism. Norred attributes that phenomenon to the area’s “hippie, free love” vibe; in many … Read more
WASHINGTON — Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” U.S. federal health officials said early Tuesday. The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of the efficacy data. AstraZeneca reported Monday that its COVID-19 … Read more
AstraZeneca announced the long-awaited results of the U.S. and South American study of its COVID-19 vaccine, and it was the first bit of positive news about the shot in recent weeks, after a parade of countries halted its use due to reports of blood clot complications. In the Phase 3 study involving more than 32,000 … Read more
LONDON — AstraZeneca says advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announced Monday. The early findings from the U.S. study are just one set … Read more
Plenty of drama in Europe this past week as the AstraZeneca vaccine—a crucial component of the continent’s vaccination plans—was paused by more than a dozen European countries after a few reports emerged of blood clots in people after receiving the vaccine. Europe’s FDA equivalent, the European Medicines Agency (EMA), says that it is still “safe … Read more
A version of this article also appeared in the It’s Not Just You newsletter. Sign up here to receive it every Sunday. Well hello! I’m so happy you’re here. This week we have a special guest columnist: Ellen Oh is an arts program director and mother of two young girls in the San Francisco Bay … Read more